Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
Saturday, May 30, 2020Daiichi Sankyo Company Limited announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck Co Inc Kenilworth New Jersey USA known as MSD outside the United States and Canada to evaluate the combination of...
CordenPharma and Moderna collaborate in obtaining the coronavirus vaccine
Friday, May 29, 2020CordenPharma a fullservice contract manufacturing and development CDMO organization for the supply of APIs Drug Products and Pharmaceutical Packaging announces the signing of a modification to its agreement to with existing manufacturing Modern Inc...
RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy With Merck’s KEYTRUDA® for Certain Late-Stage Cancers
Friday, May 29, 2020RefleXion Medical a therapeutic oncology company pioneering biologyguided radiotherapy BgRT for treating all stages of cancer today announced a clinical collaboration with Merck known as MSD outside the US and Canada to evaluate the safety and effica...
Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
Thursday, May 28, 2020Gilead Sciences Inc and Arcus Biosciences Inc an oncologyfocused biopharmaceutical company working to create bestinclass cancer therapeutics announced today that the companies have entered into a year partnership to codevelop and cocommercialize curr...
EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer
Thursday, May 28, 2020EdiGene Inc which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases and Immunochinaa company dedicated to innovative gene and cellular technology announced that they have fo...
ArcherDX Announces Strategic Collaboration with AstraZeneca
Wednesday, May 27, 2020ArcherDX Inc announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase clinical trials for AstraZenecas targeted immunooncology therapeutics
Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb
Wednesday, May 27, 2020Repare Therapeutics Inc Repare a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations today announced it has entered into an...
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies
Tuesday, May 26, 2020Tavotek Biotherapeutics a biotech company which develops novel biologics for autoimmune diseases and oncology announced that it has entered into a research agreement with Genmab AS of Denmark to create and develop bispecific antibodies using Genmabs...
Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)
Tuesday, May 26, 2020ONCODESIGN announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities spanning from Hit finding up to preparation of the Investigational New Drug filing
FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer
Monday, May 25, 2020Takeda Pharmaceutical Company Limited TSE NYSE TAK announced today that the US Food and Drug Administration FDA is approved for ALUNBRIG Brigatinib for adult patients with anaplastic lymphoma kinase ALK positive metastatic nonsmall cell lung cancer...
